Literature DB >> 17136599

Severity of illness and the welfare effects of moral hazard.

Joseph G Eisenhauer1.   

Abstract

The extent to which the moral hazard caused by health insurance represents economic inefficiency has been the subject of much debate. This paper incorporates health status in a model of moral hazard, and finds that seriously ill patients are likely to exhibit greater moral hazard than healthier patients but the proportion of moral hazard that is inefficient declines with the severity of illness. Because of these competing tendencies, the cost of resource misallocation is parabolic in the severity of illness. The effect of the consumer's initial wealth endowment is also considered.

Entities:  

Mesh:

Year:  2006        PMID: 17136599     DOI: 10.1007/s10754-006-9006-3

Source DB:  PubMed          Journal:  Int J Health Care Finance Econ        ISSN: 1389-6563


  5 in total

1.  The economics of moral hazard revisited.

Authors:  J A Nyman
Journal:  J Health Econ       Date:  1999-12       Impact factor: 3.883

2.  Benign moral hazard and the cost-effectiveness analysis of insurance coverage.

Authors:  M V Pauly; P J Held
Journal:  J Health Econ       Date:  1990       Impact factor: 3.883

3.  The welfare economics of moral hazard.

Authors:  J A Nyman; R Maude-Griffin
Journal:  Int J Health Care Finance Econ       Date:  2001-03

4.  Health insurance and the demand for medical care.

Authors:  D de Meza
Journal:  J Health Econ       Date:  1983-03       Impact factor: 3.883

5.  More on moral hazard.

Authors:  M Pauly
Journal:  J Health Econ       Date:  1983-03       Impact factor: 3.883

  5 in total
  2 in total

1.  The role and impact of cost-sharing mechanisms for prescription drug coverage.

Authors:  Marc-André Gagnon
Journal:  CMAJ       Date:  2017-05-15       Impact factor: 8.262

2.  Is 50 cent the price of the optimal copayment? - a qualitative study of patient opinions and attitudes in response to a 50 cent charge on prescription drugs in a publicly funded health system in Ireland.

Authors:  Sarah-Jo Sinnott; Marie Guinane; Helen Whelton; Stephen Byrne
Journal:  BMC Health Serv Res       Date:  2013-01-10       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.